We are live on ! Find out more
CGIM

Capital Group Investment Management Portfolio holdings

AUM $585M
1-Year Est. Return 31.36%
This Fund
S&P 500
This Quarter Est. Return
-3.35%
1 Year Est. Return
+31.36%
3 Year Est. Return
+120.23%
5 Year Est. Return
10 Year Est. Return
AUM
$585M
AUM Growth
-$30.9M
Cap. Flow
+$10.6M
Cap. Flow %
1.81%
Top 10 Hldgs %
36.6%
Holding
150
New
11
Increased
61
Reduced
45
Closed
10

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$5.05M
2
FLUT icon
Flutter Entertainment
FLUT
+$3.69M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.85M
4
CB icon
Chubb
CB
+$2.81M
5
AVGO icon
Broadcom
AVGO
+$2.71M

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 16.29%
3 Consumer Discretionary 15.05%
4 Communication Services 12.59%
5 Industrials 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
51
Abbott
ABT
$180B
$3.05M 0.52%
29,663
-5,474
-16% -$618K
CRM icon
52
Salesforce
CRM
$134B
$3.04M 0.52%
16,291
-11,075
-40% -$2.29M
CARR icon
53
Carrier Global
CARR
$57.2B
$2.81M 0.48%
49,909
-1,183
-2% -$70K
SPGI icon
54
S&P Global
SPGI
$126B
$2.75M 0.47%
6,470
+359
+6% +$167K
YUM icon
55
Yum! Brands
YUM
$41B
$2.67M 0.46%
17,151
+691
+4% +$109K
RBLX icon
56
Roblox
RBLX
$34B
$2.62M 0.45%
46,258
+4,850
+12% +$326K
PFE icon
57
Pfizer
PFE
$140B
$2.57M 0.44%
91,660
BKNG icon
58
Booking.com
BKNG
$138B
$2.55M 0.44%
15,150
-1,625
-10% -$299K
MCD icon
59
McDonald's
MCD
$188B
$2.53M 0.43%
8,139
+349
+4% +$111K
CTVA icon
60
Corteva
CTVA
$59.7B
$2.48M 0.42%
29,591
+760
+3% +$57.2K
CAT icon
61
Caterpillar
CAT
$409B
$2.46M 0.42%
+3,478
New +$2.41M
GEV icon
62
GE Vernova
GEV
$270B
$2.43M 0.42%
2,783
+62
+2% +$48.4K
CDNS icon
63
Cadence Design Systems
CDNS
$90B
$2.42M 0.41%
+8,712
New +$2.6M
HEI icon
64
HEICO Corp
HEI
$48.9B
$2.39M 0.41%
8,701
-340
-4% -$109K
LHX icon
65
L3Harris
LHX
$55.9B
$2.34M 0.4%
6,778
AON icon
66
Aon
AON
$77.3B
$2.33M 0.4%
7,219
+780
+12% +$259K
BA icon
67
Boeing
BA
$165B
$2.33M 0.4%
11,689
-127
-1% -$28.9K
KEYS icon
68
Keysight
KEYS
$54.5B
$2.31M 0.4%
8,193
-438
-5% -$110K
REGN icon
69
Regeneron Pharmaceuticals
REGN
$68.8B
$2.27M 0.39%
2,938
+71
+2% +$54.4K
ALGN icon
70
Align Technology
ALGN
$12B
$2.24M 0.38%
13,071
+110
+0.8% +$19.3K
STZ icon
71
Constellation Brands
STZ
$22.2B
$2.24M 0.38%
14,915
+1,449
+11% +$224K
KKR icon
72
KKR & Co
KKR
$89.2B
$2.24M 0.38%
24,184
+6,075
+34% +$640K
SLB icon
73
SLB Ltd
SLB
$77.8B
$2.18M 0.37%
42,329
-4,776
-10% -$232K
ALNY icon
74
Alnylam Pharmaceuticals
ALNY
$36.3B
$2.14M 0.37%
6,474
-8,372
-56% -$2.85M
WPM icon
75
Wheaton Precious Metals
WPM
$50.6B
$2.12M 0.36%
+16,185
New +$2.25M

Similar funds

Capital Group Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Capital Group Investment Management held 150 positions worth $585M, down 5% from $616M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Capital Group Investment Management's Q1 2026 filing shows 11 new, 61 increased, 45 reduced and 10 closed positions. Its largest new stake was AstraZeneca: 99,013 shares worth $19.3M. The largest sale was Synopsys, an estimated $5.05M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Group Investment Management's largest Q1 2026 buy was AstraZeneca: 99,013 shares worth $19.3M.
  • Capital Group Investment Management added most to NVIDIA in Q1 2026, an estimated $4.93M increase.
  • Capital Group Investment Management's biggest Q1 2026 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.85M.
  • Capital Group Investment Management fully exited Synopsys in Q1 2026, selling an estimated $5.05M.
  • Capital Group Investment Management's ten largest holdings make up 37% of its $585M portfolio in Q1 2026.
  • Capital Group Investment Management opened 11 new positions and closed 10 in Q1 2026.
  • Capital Group Investment Management's portfolio value fell 5% quarter-over-quarter to $585M.

Based on Capital Group Investment Management's 13F filing for Q1 2026, filed 13 May 2026.